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Abstract
Introduction:  Salicylate  at  high  doses  induces  tinnitus  in  humans  and  experimental  animals.
However,  the  mechanisms  and  loci  of  action  of  salicylate  in  inducing  tinnitus  are  still  not  well
known. The  expression  of  Immediate  Early  Genes  (IEG)  is  traditionally  associated  with  long-
term neuronal  modiﬁcations  but  it  is  still  not  clear  how  and  where  IEGs  are  activated  in  animal
models of  tinnitus.
Objectives:  Here  we  investigated  the  expression  of  c-fos  and  Egr-1,  two  IEGs,  in  the  Dorsal
Cochlear Nucleus  (DCN),  the  Inferior  Colliculus  (IC),  and  the  Posterior  Ventral  Cochlear  Nucleus
(pVCN) of  rats.
Methods:  Rats  were  treated  with  doses  known  to  induce  tinnitus  in  rats  (300  mg/kg  i.p.  daily,
for 3  days),  and  c-fos  and  Egr-1  protein  expressions  were  analyzed  using  western  blot  and
immunocytochemistry.
Results: After  administration  of  salicylate,  c-fos  protein  expression  increased  signiﬁcantly  in
the DCN,  pVCN  and  IC  when  assayed  by  western  blot.  Immunohistochemistry  staining  showed
a more  intense  labeling  of  c-fos  in  the  DCN,  pVCN  and  IC  and  a  signiﬁcant  increase  in  c-fos
positive nuclei  in  the  pVCN  and  IC.  We  did  not  detect  increased  Egr-1  expression  in  any  of  these
areas.
Conclusion:  Our  data  show  that  a  high  dose  of  salicylate  activates  neurons  in  the  DCN,  pVCN
and IC.  The  expression  of  these  genes  by  high  doses  of  salicylate  strongly  suggests  that  plastic
changes in  these  areas  are  involved  in  the  genesis  of  tinnitus.
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Expressão  especíﬁca  de  gene  precoces  imediatos  induzida  por  doses  elevadas  de
salicilato  no  núcleo  coclear  e  colículo  inferior  de  rato
Resumo
Introduc¸ão:  Salicilato  em  doses  elevadas  induz  zumbido  nos  seres  humanos  e  em  animais  exper-
imentais. No  entanto,  os  mecanismos  e  loci  de  ac¸ão  do  salicilato  na  induc¸ão  de  zumbido  ainda
não são  bem  conhecidos.  A  expressão  dos  genes  precoces  imediatos  (GPIs)  está  tradicional-
mente associada  a  alterac¸ões  neuronais  em  longo  prazo,  mas  ainda  não  está  claro  como  e  onde
os GPIs  são  ativados  em  modelos  animais  de  zumbido.
Objetivos:  No  presente  estudo  investigamos  a  expressão  de  c-fos  e  Egr-1,  dois  GPIs,  no  núcleo
coclear dorsal  (NCD),  colículo  inferior  (CI)  e  núcleo  coclear  ventral  posterior  (NCVp)  de  ratos.
Métodos:  Os  ratos  foram  tratados  com  doses  que,  conhecidamente,  induzem  zumbido  em  ratos
(300 mg/kg  IP/dia,  por  três  dias)  e  as  expressões  das  proteínas  c-fos  e  Egr-1  foram  analisadas
por meio  de  Western  blot  e  imunoistoquímica.
Resultados:  Após  a  administrac¸ão  de  salicilato,  a  expressão  da  proteína  c-fos  aumentou
signiﬁcativamente  no  NCD,  NCVp  e  CI,  quando  analisados  por  Western  blot.  A  colorac¸ão  imunois-
toquímica mostrou  uma  marcac¸ão  mais  intensa  de  c-fos  no  NCD,  NCVp  e  CI  e  um  aumento
signiﬁcativo  de  núcleos  positivos  de  c-fos  no  NCVp  e  CI.  Não  detectamos  aumento  da  expressão
de Egr-1  em  nenhuma  dessas  áreas.
Conclusão:  Nossos  dados  mostram  que  uma  dose  alta  de  salicilato  ativa  neurônios  no  NCD,  NCVp
e CI.  A  expressão  desses  genes  por  doses  altas  de  salicilato  sugere  que  as  alterac¸ões  plásticas
nessas áreas  estão  envolvidas  na  gênese  do  zumbido.
© 2016  Publicado  por  Elsevier  Editora  Ltda.  em  nome  da  Associação  Brasileira  de  Otorrino-
laringologia  e  Cirurgia  Cérvico-Facial.  Este  é  um  artigo  Open  Access  sob  a  licença  de  CC  BY
(http://creativecommons.org/licenses/by/4.0/).
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innitus  is  a  phantom  sound  sensation  that  can  be  the  conse-
uence  of  several  factors  including  acoustic  trauma,  drugs,
emporal  mandibular  disorders  or  deafness.1 The  mech-
nisms  of  tinnitus  induction  and  maintenance  are  still  a
atter  of  debate,  especially  since  tinnitus  can  result  from
everal  different  conditions.  High  doses  of  salicylate  induce
innitus  in  humans,  and  at  doses  of  150--400  mg/kg  it  induces
ehavioral  symptoms  of  tinnitus  in  experimental  animals  in
ess  than  24  h;  this  effect  subsides  within  72  h  after  treat-
ent  interruption.2
Despite  the  common  use  of  salicylate  as  a  tinnitus-
nducing  agent,  its  mechanisms  and  loci  of  action  are  still
bscure.  In  vivo  imaging  experiments  in  rats  have  shown
hat  high  doses  of  salicylate  induces  hyperactivity  in  spe-
iﬁc  auditory  areas,  including  the  Inferior  Colliculus  (IC),
he  Dorsal  Cochlear  Nucleus  (DCN)  and  the  Auditory  Cor-
ex  (AC),  but  not  the  Ventral  Cochlear  Nucleus  (VCN).3,4
n  the  other  hand,  studies  of  expression  of  the  immedi-
te  early  gene  c-fos  showed  less  consistent  results.  A  single
ose  of  salicylate  (350  mg/kg)  increased  c-fos  expression
nly  in  the  AC  of  gerbils.5 A  previous  study  did  not  show
-fos  expression  in  the  auditory  brainstem  after  a single
ose  of  salicylate,  but  only  in  non-auditory  areas  such  as
he  locus  coeruleus  and  periaqueductal  gray  area.6 Another
tudy  observed  a  decrease  of  c-fos  expression  in  the  IC  of
7erbils. Another  study  using  chronic  treatment  with  salicy-
ate  (250  mg/mL)  showed  increased  c-fos  expression  only  in
he  IC  and  not  in  the  DCN.8 Most  of  these  data  are  inconsis-
ent  with  the  observations  that  tinnitus  induced  by  salicylate
t
r
m
wctivates  extralemniscal  auditory  pathways,  especially  the
CN.2,3
The  expression  of  Immediate  Early  Genes  (IEGs)  is  con-
idered  a  marker  of  increased  brain  activity  in  response  to
iverse  stimuli.  These  genes  are  transcription  factors  that
rigger  the  expression  of  other  genes  responsible  for  long-
erm  changes  in  neurons.  The  expression  of  the  IEG  c-fos
s  a  commonly  used  marker  of  neuronal  activity  and  it  is
uickly  upregulated  after  neuronal  stimulation.9--12 The  IEG
gr-1  is  activated  in  response  to  neuronal  calcium  inﬂux
nd  promotes  functional  and  structural  changes  in  neurons,
ncluding  in  the  auditory  system.13,14
In  this  study,  we  aimed  to  investigate  the  activation  of
-fos  and  Egr-1  in  the  DCN  and  IC  in  auditory  pathways  of
ats  subjected  to  a  protocol  of  salicylate  administration,
hich  is  effective  in  inducing  tinnitus  in  rats  (3  daily  doses  of
00  mg/kg).3 Due  to  its  proximity  to  the  DCN  we  also  studied
he  expression  of  these  genes  in  the  posterior  division  of  the
entral  Cochlear  Nucleus  (pVCN).
ethods
nimals  and  drug  treatment
ll  experimental  procedures  performed  on  animals  were
pproved  by  the  institution’s  Animal  Care  and  Use  Commit-
ee  (protocol  n◦ 011/2013)  and  followed  the  guidelines  and
ecommendations  of  the  National  Institutes  of  Health  on  ani-
al  care.  Experiments  were  performed  on  male  Wistar  rats
eighing  60--65  g.  Rats  were  group-housed  four  to  ﬁve  per
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Figure  1  c-fos  expression  in  the  CN.  Top.  quantiﬁcation  of
c-fos expression.  The  c-fos  signal  intensity  was  normalized  to
the GAPDH  signal  intensity  (**p =  0.0058;  n  =  5  for  each  group
containing  material  from  4  animals).  Western  blots  showing  the
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Speciﬁc  immediate  early  gene  expression  induced  by  high  d
cage  and  kept  under  a  12  hour  light/dark  cycle  with  food
and  water  ad  libitum.
Animals  were  injected  i.p.  with  300  mg/kg  sodium  sal-
icylate  (Sigma)  (10  L/g),  dissolved  in  saline,  for  three
consecutive  days  with  a  24  hour  interval  between  each  dose.
The  animals  were  then  anesthetized  with  isoﬂurane  and
killed  by  decapitation  on  the  third  day,  3  h  after  drug  admin-
istration.  Control  groups  were  administered  saline  following
the  same  protocol.  This  protocol  of  salicylate  administration
has  been  demonstrated  to  be  effective  in  inducing  tinnitus
in  rats.3
Detection  of  Egr-1  and  c-fos  by  western  blotting
Forty  animals  were  used  for  these  experiments:  20  were
naïve  animals  and  20  were  submitted  to  salicylate  treat-
ment.  Slides  with  fresh  sections  (90  m)  of  the  brainstem
containing  the  pVCN,  DCN  and  IC  were  obtained  in  a  cryo-
stat.  To  obtain  a  tissue  punch  of  the  desired  area  we  used
a  metal  cylinder  with  a  pistil  of  0.5  mm  diameter.  Due  to
their  small  size  and  contiguous  location,  the  DCN  and  pVCN
were  extracted  in  the  same  punch.  One  punch  was  obtained
from  each  of  four  animals  and  they  were  pooled  to  increase
protein  yield.  The  tissue  was  homogenized  in  a  lysis  buffer
containing  137  mM  NaCl,  20  mM  Tris,  1%  Igepal  CA-630,  10%
glycerol,  2  mM  sodium  orthovanadate,  1%  sodium  dodecyl
sulphate,  50  mM  sodium  ﬂuoride,  2  mM  EDTA,  and  10%  pro-
tease  inhibitor  cocktail  at  pH  7.4.  Tissue  homogenates  were
centrifuged  at  15,000  rpm  for  10  min  at  4 ◦C.  Protein  concen-
tration  in  tissues  homogenates  was  determined  using  a
modiﬁed  Lowry  assay  (DC  Protein  Assay,  Bio-Rad).  Aliquots
containing  90  g  protein  were  dissolved  in  loading  buffer
and  heated  at  95 ◦C  for  5  min,  and  the  proteins  separated  by
7.5%  Tris--glycine  SDS-PAGE  (GE  Healthcare-Bioscience)  and
transferred  to  PVDF  membranes  (Amersham  Biosciences).
Immunoblots  were  blocked  with  albumin  5%  and  incu-
bated  with  primary  antibodies  at  4 ◦C.  Primary  antibodies
included  antibodies  against  c-fos  and  Egr-1  (1:1000;  Santa
Cruz  Biotechnology).  After  incubation,  membrane  was
washed  and  incubated  with  secondary  antibody  (1:10,000;
ECL  anti-Rabbit  IgG;  GE  Healthcare)  for  1  h  at  room  temper-
ature.  After  ﬁnal  washes,  labeled  proteins  were  detected  by
chemiluminescence  (RPN2132;  GE  Healthcare).  For  stripping
and  reprobing,  the  membrane  was  submerged  in  stripping
buffer  (100  mM  20-mercaptoethanol,  2%  sodium  dodecyl  sul-
phate,  62.5  mM  Tris--HCl,  pH  6.8)  at  50 ◦C,  for  8  min,  washed
for  90  min  under  tap  water,  rehydrated  with  methanol  and
washed  with  TBS-T  before  blocking  and  reprobed  with  pri-
mary  antibody  against  GAPDH  (1:5000;  Abcam).  Western
blots  were  photographed  and  quantiﬁed  with  image  analysis
(Molecular  Imaging  Systems).
c-fos  Immunohistochemistry
Ten  rats  were  used,  5  naïve  and  5  submitted  to  salicy-
late  treatment.  Rats  were  perfused  transcardially  with  0.9%
NaCl  followed  by  4%  paraformaldehyde  in  0.1  M  phosphate
buffer  (pH  7.4).  The  brain  was  removed,  postﬁxed  in  the
same  solution  for  1  h,  and  cryoprotected  with  30%  sucrose
in  0.1  M  phosphate  buffer  for  2  days  at  4 ◦C.  The  brains  were
p
p
I
lmmunoreactivity  of  c-fos  and  GAPDH  in  punches  containing  the
N (N,  naïve;  S,  salicylate).
ndividually  sectioned  (50  m)  in  the  transverse  plane  using
 cryostat.
The sections  were  washed  in  PBS  (0.01  M,  pH  7.4)  and
ncubated  for  30  min  in  PBS  containing  1%  hydrogen  per-
xide  to  inactivate  endogenous  peroxidases.  After  several
inses  in  PBS  for  30  min,  the  sections  were  placed  in  5%  nor-
al  goat  serum  (Vector)  for  1  h  and  incubated  for  48  h  at  4 ◦C
ith  primary  anti  c-fos  antibody  generated  in  rabbits  (1:100;
anta  Cruz).  After  rinsed  in  PBS,  the  sections  were  incu-
ated  for  1.5  h  at  room  temperature  with  biotinylated  goat
nti-rabbit  IgG  (1:150;  Vector);  then,  subsequently,  washed
n  PBS  and  placed  for  1.5  h  in  avidin--biotin  peroxidase  com-
lex  (Vectastain,  Vector).  The  immunolabeling  was  revealed
y  5--10  min  of  incubation  with  0.05%  3,3′-diaminobenzidine
etrachloride  and  0.1%  hydrogen  peroxide.  The  sections
ere  mounted  on  gelatin-coated  slides,  dehydrated,  cleared
ith  xylene  and  coverslipped  with  Entellan®.
ata  analysis
estern  blot  data  are  presented  as  the  ratio  of  c-fos  and
APDH  signal  intensity.  Stained  nuclei  in  ICC  sections  were
ounted  manually.  Eleven  sections  containing  the  IC,  9  con-
aining  the  DCN  and  6  containing  the  pVCN  were  counted  for
ach  animal.  All  data  are  expressed  as  mean  ±  SD.  Statisti-
al  analysis  was  carried  out  using  Student’s  t-test.  p  <  0.05
as  considered  statistically  signiﬁcant.
esults
fter  3 days  of  salicylate  treatment  (300  mg/kg)  we  removed
unches  of  brainstem  containing  the  IC  and  both  the  DCN  and
VCN  for  western  blot  analysis  of  c-fos  protein  expression.
n  both  areas  c-fos  was  signiﬁcantly  increased  after  salicy-
ate  treatment  (Figs.  1  and  2).  In  contrast,  increased  Egr-1
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Figure  2  c-fos  expression  in  the  IC.  Top  quantiﬁcation  of  c-
fos expression.  The  c-fos  signal  intensity  was  normalized  to  the
GAPDH  signal  intensity  (**p  =  0.0012;  n  =  5  for  each  group  con-
taining  material  from  4  animals).  Western  blots  showing  the
immunoreactivity  of  c-fos  and  GAPDH  in  punches  containing  the
IC (N,  naïve;  S,  salicylate).
CN
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N NS S S
SSS NN
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Figure  3  Western  blots  showing  the  immunoreactivity  of  Egr-
1 in  punches  containing  the  DCN/pVCN  and  IC  from  naïve  rats
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ing  neurons,  which  could  explain  the  non-signiﬁcant  effect
of  salicylate  in  the  number  of  c-fos  labeled  nuclei  in  the  DCN.nd after  sodium  salicylate  treatment  (N,  naïve;  S,  salicylate).
rotein  expression  was  not  detected  after  salicylate  treat-
ent  in  these  regions  (Fig.  3).
Because  the  location  of  the  c-fos  protein  cannot  be
dentiﬁed  by  Western  Blot,  we  performed  c-fos  immunocy-
ochemistry  in  sections  containing  the  DCN,  pVCN  and  the
C.  We  detected  c-fos  in  sections  of  the  DCN,  pVCN  and  IC,  as
hown  in  Fig.  4.  In  sections  from  naïve  animals  faint  nuclei
taining  was  observed  in  all  3  regions  (Fig.  4A).  In  sections
rom  salicylate  treated  animals  we  observed  more  intense
abeled  nuclei  in  DCN,  pVCN  and  IC  (Fig.  4B).  In  the  DCN  this
ntensely  c-fos  labeling  was  observed  in  the  more  internal
ayers,  the  deep  layer  and  possibly  the  fusiform  layer  (Fig.  4B
nd  C),  and  it  was  observed  mostly  in  the  medial/dorsal  sec-
ion  of  the  DCN.  We  did  not  observe  labeling  in  the  molecular
ayer.  We  also  observed  increased  c-fos  labeling  in  the  pVCN
djacent  to  the  DCN  (Fig.  4B  and  D).  In  the  IC  we  observed  an
ncrease  in  the  immunoreactivity  mostly  in  the  central  part,
s  can  be  seen  in  Fig.  4E  and  F.  No  labeling  was  observed  in
he  superior  olive  (not  shown).
Quantitative  analysis  of  nuclei  expressing  c-fos  showed
 signiﬁcant  increase  of  c-fos  positive  nuclei  in  the
VCN  (naïve:  155  ±  9.2  nuclei;  salicylate:  228  ±  26.4  nuclei; =  0.04,  n  =  4)  and  in  the  IC  (naïve:  1190  ±  86  nuclei;  salicy-
ate:  1611  ±  79  nuclei;  p  =  0.0061;  n  =  5),  but  not  in  the  DCN
O
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naïve:  135  ±  15  nuclei;  salicylate:  170  ±  9.5  nuclei;  p  =  0.1;
 =  4),  as  can  be  seen  in  Fig.  4G.
iscussion
ur  data  show  that  3  days  of  treatment  with  high  doses  of
alicylate  increase  the  expression  of  the  products  of  the
EG  c-fos,  but  not  of  Egr-1,  in  pVCN,  DCN  and  IC  of  rats.
lthough  we  observed  increased  c-fos  protein  levels  and
 more  intense  nuclei  labeling  in  the  IC,  DCN  and  pVCN
fter  salicylate,  the  number  of  stained  nuclei  was  signiﬁ-
antly  increased  only  in  the  pVCN  and  IC  and  not  in  the  DCN.
his  data  is  in  accordance  with  the  observed  hyperactivity
f  the  DCN  and  IC  in  rats  submitted  to  a  similar  protocol
f  salicylate  treatment3,15,16 and  in  other  animal  models
f  tinnitus.17,18 On  the  other  hand,  we  found  a  signiﬁcant
ncrease  in  c-fos  expression  in  the  adjacent  pVCN,  a  region
ot  usually  related  to  tinnitus  induction.3 This  increased
xpression  of  c-fos  in  DCN,  pVCN  and  IC  suggests  that  the
xpression  of  these  IEGs  promotes  the  expression  of  pro-
eins  that  can  change  the  physiological  and  morphological
roperties  of  the  neurons  of  these  regions,  which  could  be
 substrate  for  tinnitus  induction.
Others4--7 studied  c-fos  expression  after  acute  salicylate
reatment  using  immunocytochemistry.  Those  studies  found
hat  c-fos  expression  was  not  consistently  increased  in  the
CN  and  IC.  Our  results  on  the  other  hand  show  a  clearly
ncreased  expression  of  c-fos  positive  nuclei  in  the  IC  and
VCN.  We  believe  these  discrepancies  can  be  attributed  to
he  fact  that  we  used  younger  animals  and  that  those  studies
sed  a single  dose  of  sodium  salicylate,  instead  of  the  3  daily
oses  used  by  this  study.  Consistent  with  this  hypothesis,  a
tudy  using  6 days  of  treatment  with  salicylate  also  observed
 signiﬁcant  increase  of  c-fos  positive  nuclei  in  the  IC,  but
ot  in  the  DCN.8
In  experimental  animals  salicylate  treatment  increases
he  ﬁring  of  neurons  in  both  DCN  and  IC.15,16 The  mech-
nisms  of  this  effect  are  still  unknown  and  could  reﬂect
 direct  effect  of  salicylate  on  the  neuronal  excitabil-
ty  of  these  neurons  or  their  incoming  synapses,  or  a
ownstream  effect  of  salicylate-induced  gene  expression.
ontrary  to  a  direct  excitatory  effect  of  salicylate,  it  has
een  shown  that  direct  application  of  salicylate  on  DCN  neu-
ons  in  brain  slices  decreases  the  spontaneous  and  evoked
ring  of  DCN  principal  neurons.19,20 On  the  other  hand,
irect  application  of  salicylate  increases  the  ﬁring  of  most
C  neurons  in  vitro.21 Salicylate  could  also  enhance  the
xcitability  of  DCN  and  IC  neurons  by  decreasing  their
lycinergic  inhibitory  transmission.22 However,  glycinergic
urrents  in  DCN  fusiform  neurons  were  not  affected  by  acute
pplications  of  millimolar  concentrations  of  salicylate.20
alicylate  can  also  inhibit  GABAergic  receptors23 and
nhance  NMDA  currents24 which  could  potentially  disturb  the
xcitation-inhibition  balance.  Because  most  DCN  neurons
re  spontaneously,25 a  ﬁring  increase  produced  by  salicylate
ight  not  increase  signiﬁcantly  the  number  of  c-fos  express-n  the  other  hand,  our  data  showed  a signiﬁcant  increase  in
-fos  expressing  nuclei  expression  in  the  pVCN,  suggesting
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Figure  4  Detection  of  c-fos  by  immunocytochemistry  in  the  DCN  and  IC.  (A)  Section  containing  the  DCN  and  posterior  Ventral
Cochlear Nucleus  (pVCN)  from  a  naïve  animal.  (B)  Section  containing  the  DCN  and  posterior  Ventral  Cochlear  Nucleus  (pVCN)  from
an animal  treated  with  salicylate.  (C)  Detail  of  the  c-fos  expressing  nuclei  in  the  DCN  from  the  square  area  shown  in  (B).  (D)  Detail  of
the c-fos  expressing  nuclei  in  the  pVCN  from  the  square  area  shown  in  (B).  (E)  Section  containing  the  IC  from  an  animal  treated  with
 the
N,  p
esalicylate. (F)  Detail  of  the  c-fos  expressing  nuclei  in  the  IC  from
of c-fos  in  the  DCN,  pVCN  and  IC  [*p  =  0.04;  **p  =  0.006;  n  =  4  (DC
that  salicylate  is  activating  its  neurons,  and  that  this  region
could  be  relevant  for  the  perception  of  tinnitus.
Both  c-fos  and  Egr-1  are  expressed  in  the  audi-
tory  pathways  in  response  to  sound  and  intracochlear
stimulation.10,12,26,27 Interestingly,  in  the  DCN  c-fos
m
l
d
f square  area  shown  in  (E).  (G)  Quantiﬁcation  of  the  expression
VCN)  and  5  (IC)].
xpression  elicited  by  intracochlear  stimulation  was
ost  observed  in  glycinergic  interneurons  in  the  molecular
ayer.27 This  ﬁnding  is  intriguing  because  these  interneurons
o  not  receive  input  from  the  primary  auditory  pathway,  but
rom  the  parallel  ﬁbers,  which  convey  mostly  somatosensory
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nformation.  We  only  observed  c-fos  labeling  near  or  in
he  deep  layer  of  the  DCN  in  both  control  and  salicylate
onditions,  suggesting  that  c-fos  is  expressed  mainly  by
eurons  computing  the  auditory  information.  On  the  other
and,  we  did  not  ﬁnd  expression  of  Egr-1,  a  IEG  that  is  linked
o  the  formation  of  long-term  plasticity13 after  salicylate
reatment,  suggesting  that  salicylate  does  not  trigger  the
xpression  of  genes  related  to  long-term  synaptic  plasticity.
nterestingly,  a  previous  study  found  a  decrease  in  Egr-1
ene  expression  after  salicylate  treatment  in  the  IC.28
There  are  similarities  of  tinnitus  with  neuropathic
ain,29,30 suggesting  that  they  could  share  similar  molecu-
ar  mechanisms.  For  instance,  patients  with  tinnitus  often
resent  with  hyperacusis,  and  patients  with  chronic  pain,
yperalgesia,  both  of  which  are  enhanced  reactions  to
ormal  stimuli  intensities.  Like  tinnitus,31 chronic  pain  is
elieved  to  be  a  result  of  long-term  plastic  changes  in
ensory  neurons  and  synapses.32 The  IEG  c-fos  is  also  acti-
ated  in  the  spinal  cord  in  models  of  chronic  pain  and
nﬂammation.33,34 Their  expression  is  postulated  to  be  the
rst  signal  of  long-term  changes  in  these  neurons  which  will
ead  to  chronic  pain.  Thus,  it  is  likely  that  c-fos  is  acti-
ating  similar  cascades  of  gene  expression  in  tinnitus  and
hronic  pain,  leading  to  changes  that  would  underlie  the
ymptomatology  of  these  conditions.
onclusions
ur  data  shows  that  tinnitus-inducing  doses  of  salicylate3
ncrease  c-fos,  but  not  Egr-1,  expression  in  auditory  areas
f  the  auditory  brainstem,  the  dorsal  cochlear  nucleus,  the
osteroventral  cochlear  nucleus  and  inferior  colliculus  of  the
at.  Thus,  we  postulate  that  c-fos  is  activating  cascades  of
ene  expression  in  these  areas  leading  to  changes  that  could
nderlie  the  symptomatology  of  tinnitus.
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